Results 251 to 260 of about 215,213 (307)

HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering. [PDF]

open access: yesJ Immunother Cancer
Zhao J   +32 more
europepmc   +1 more source

Immune cells in keloids: mechanisms and potential treatments. [PDF]

open access: yesAnn Med
Wu Y, Huang Y, Zhang H, Dong C, Chen X.
europepmc   +1 more source

Substrate Characterization of Mycobacterial Kinase PknG Revealing PknG‐KARS‐MAPK Phosphorylation Signaling Axis in Host

open access: yesiMetaMed, EarlyView.
This study employed multi‐omics approaches to investigate the regulatory mechanism of Mycobacterium PknG on host cell processes. We found that host lysine‐tRNA ligase (KARS) is a potential substrate of PknG; and PknG can regulate the immune response by catalyzing the phosphorylation of KARS at T592 and T595 sites, affecting the phosphorylation level in
Nana Tian   +13 more
wiley   +1 more source

Abatacept treatment shows a modulating effect on Treg subsets in LRBA-deficient patients. [PDF]

open access: yesFront Immunol
Donhauser S   +6 more
europepmc   +1 more source

Treg cells retain stable lineage commitment during pregnancy in mice after late gestation inflammatory challenge. [PDF]

open access: yesImmunol Cell Biol
Foyle KL   +6 more
europepmc   +1 more source

Roseburia intestinalis ameliorates adolescent depression via GPR43‑dependent Treg cell expansion and suppression of neuroinflammation. [PDF]

open access: yesJ Neuroinflammation
Liu J   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy